Lam Research (LRCX) is back in focus after announcing plans to invest more than US$3b over five years to expand its global R&D lab network and significantly increase experiment capacity.

The R&D expansion news arrives following a strong run in Lam Research's stock, with the share price at US$332.36 and a year-to-date share price return of 79.60%. The 1-year total shareholder return is 235.85%, and the 5-year figure is more than 5x.

If you are looking beyond Lam Research and want to see where other chip-related ideas are gaining traction, check out our screener of 55 AI infrastructure stocks

Lam Research now trades close to analyst targets, yet the modeled intrinsic value points much lower. Is the recent surge overreaching fair value, or are cautious assumptions leaving upside on the table as you look at the numbers next?

Most Popular Narrative: 3% Overvalued

The most followed narrative for Lam Research currently places fair value at $323.38, which sits below the last close at $332.36 and presents a slightly stretched valuation story.

Lam's leadership in new process technologies, such as ALD Moly for metal deposition and advanced packaging solutions (SABRE 3D systems), positions the company to capture an increasing share of spend on next-generation chip manufacturing, leading to market share gains, higher average selling prices, and expanding gross margins over the long term.

Want to see what justifies Lam Research trading ahead of this fair value line? The narrative leans on ambitious revenue compounding, wider margins and a rich future earnings multiple. Curious which assumptions really carry the model?

Result: Fair Value of $323.38 (OVERVALUED)

However, Lam Research's heavy exposure to China and reliance on a small group of large chipmakers mean any capex pullback or export restrictions could quickly challenge this upbeat narrative.

Next Steps

With both optimism and concern in the mix for Lam Research, it makes sense to move quickly and test the story against the numbers yourself. To see how the bright spots stack up against the red flags in one place, review the 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Lam Research?

If you stop with Lam Research, you might overlook other compelling setups. Use the screener to compare opportunities side by side and pressure test your next move.

• Spot companies that combine quality with attractive prices by reviewing the 52 high quality undervalued stocks.
• Strengthen your search for stability by checking out the 80 resilient stocks with low risk scores.
• Get ahead of the crowd by scanning the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.